Can low total IgM weaken early infection defense without proving active Borrelia infection?

In an 83-year-old man, low total IgM and a positive Borrelia-specific IgM address different questions: potential immune function versus evidence for current Lyme borreliosis.

Early immune defense

• Natural and rapidly induced IgM provides broad early microbial recognition before mature antigen-specific responses develop. Antigen-bound IgM recruits C1q, activates the classical complement pathway, promotes C3 opsonization, and facilitates complement-receptor-mediated phagocytic clearance.
• Therefore, reduced functionally relevant IgM could weaken an early antibody-mediated clearance pathway. This is biologically plausible, but a low total serum IgM concentration is not a direct measure of pathogen-reactive IgM, complement-fixing activity, or vaccine responsiveness.
• Selective IgM deficiency cohorts report recurrent respiratory infections, but clinical susceptibility varies. Strict definitions may include preserved vaccine responses, illustrating that low IgM concentration can coexist with adequate functional immunity.

Interpreting Borrelia IgM

• A Borrelia-specific IgM result alone cannot determine whether infection is active. Following treated Lyme disease, IgM reactivity persisted for 10–20 years in 10% of people treated for early Lyme disease and 15% treated for Lyme arthritis.
• Isolated IgM also has substantial false-positive potential: 53% of positive IgM immunoblots in one referred cohort were considered false positive, and another retrospective analysis found approximately half of isolated-IgM-based diagnoses unlikely to represent Lyme disease.
• CDC interpretation restricts IgM immunoblot use to compatible illness lasting ≤30 days. After 30 days, IgM should be disregarded, with assessment relying on IgG, compatible symptoms and exposure history, and validated two-tier testing.

Bottom line

• Low total IgM may plausibly impair early complement-assisted antimicrobial defense, but does not by itself define clinically important immune dysfunction. Conversely, antigen-specific Borrelia IgM—especially if isolated or obtained after prolonged symptoms—does not establish active Lyme infection.